Erschienen in:
01.07.2013 | Editorial
Can a serological test for selecting high-risk groups before endoscopy reduce gastric cancer deaths?
verfasst von:
Osamu Hosokawa
Erschienen in:
Gastric Cancer
|
Ausgabe 3/2013
Einloggen, um Zugang zu erhalten
Excerpt
Each year 700,000 patients die from gastric cancer around the world. The incidence of gastric cancer death varies among countries and populations. East Asia, Eastern Europe, and parts of Central and South America have higher gastric cancer death rates. For advanced disease, operation combined with chemotherapy using new drugs has become the standard treatment in all countries. However, the prognosis still remains poor and, therefore, early detection and early treatment via screening are considered useful strategies to reduce gastric cancer death rates. An efficient and cost-effective practical mass screening method is necessary. The majority of countries, even those with high rates of the disease, have no national guidelines or recommendations for gastric cancer screening. A mass screening method for gastric cancer is used in only two countries, Japan and Korea. …
